Alec Machiels Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Alec Machiels is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 370,761 shares of APLS, which is worth approximately $12.1 Million. The most recent transaction as insider was on Jan 01, 2023, when has been sold 3,867 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K

0% 3M change

0.91% 12M change

Total Value Held $12.1 Million

Alec Machiels Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2023	BUY Grant, award, or other acquisition	-	3,867 Added 1.42%	267,641 Common Stock
Dec 15 2022	SELL Open market or private sale	$65,437 $52.35 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Dec 15 2022	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Nov 15 2022	SELL Open market or private sale	$60,012 $48.01 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	$3,337 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Oct 14 2022	SELL Open market or private sale	$74,138 $59.31 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Oct 14 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Sep 15 2022	SELL Open market or private sale	$82,500 $66.0 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Sep 15 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Aug 15 2022	SELL Open market or private sale	$84,012 $67.21 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Jul 15 2022	SELL Open market or private sale	$57,913 $46.33 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Jul 15 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Jun 15 2022	SELL Open market or private sale	$49,113 $39.29 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
May 16 2022	SELL Open market or private sale	$48,975 $39.18 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Apr 14 2022	SELL Open market or private sale	$63,625 $50.9 p/Share	1,250 Reduced 0.47%	263,774 Common Stock
Apr 14 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.47%	265,024 Common Stock
Mar 15 2022	SELL Open market or private sale	$49,462 $39.57 p/Share	1,250 Reduced 0.48%	259,544 Common Stock
Mar 15 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.48%	260,794 Common Stock
Feb 15 2022	SELL Open market or private sale	$56,788 $45.43 p/Share	1,250 Reduced 0.19%	673,774 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.18%	675,024 Common Stock
Jan 14 2022	SELL Open market or private sale	$50,700 $40.56 p/Share	1,250 Reduced 0.19%	673,774 Common Stock
Jan 14 2022	BUY Exercise of conversion of derivative security	$3,338 $2.67 p/Share	1,250 Added 0.18%	675,024 Common Stock

Alec Machiels

Director

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account